Virus de l'immunodéficience simienne : Questions médicales fréquentes
Nom anglais: Simian Immunodeficiency Virus
Descriptor UI:D015302
Tree Number:B04.820.650.805.700
Termes MeSH sélectionnés :
Machine Learning
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus de l'immunodéficience simienne : Questions médicales les plus fréquentes",
"headline": "Virus de l'immunodéficience simienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus de l'immunodéficience simienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-04",
"dateModified": "2025-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus de l'immunodéficience simienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Rétrovirus simiens",
"url": "https://questionsmedicales.fr/mesh/D015301",
"about": {
"@type": "MedicalCondition",
"name": "Rétrovirus simiens",
"code": {
"@type": "MedicalCode",
"code": "D015301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.650.805"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus de l'immunodéficience simienne",
"alternateName": "Simian Immunodeficiency Virus",
"code": {
"@type": "MedicalCode",
"code": "D015302",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Woong-Ki Kim",
"url": "https://questionsmedicales.fr/author/Woong-Ki%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA."
}
},
{
"@type": "Person",
"name": "Hui Li",
"url": "https://questionsmedicales.fr/author/Hui%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA."
}
},
{
"@type": "Person",
"name": "Katharine J Bar",
"url": "https://questionsmedicales.fr/author/Katharine%20J%20Bar",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA bark@pennmedicine.upenn.edu."
}
},
{
"@type": "Person",
"name": "Bapi Pahar",
"url": "https://questionsmedicales.fr/author/Bapi%20Pahar",
"affiliation": {
"@type": "Organization",
"name": "Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United States."
}
},
{
"@type": "Person",
"name": "Arpita Das",
"url": "https://questionsmedicales.fr/author/Arpita%20Das",
"affiliation": {
"@type": "Organization",
"name": "Division of Microbiology, Tulane National Primate Research Center, Covington, LA, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Using unsupervised machine learning to classify behavioral risk markers of bacterial vaginosis.",
"datePublished": "2024-02-03",
"url": "https://questionsmedicales.fr/article/38310145",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07360-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Machine Learning Study of Anxiety-related Symptoms and Error-related Brain Activity.",
"datePublished": "2024-02-02",
"url": "https://questionsmedicales.fr/article/38319886",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1162/jocn_a_02126"
}
},
{
"@type": "ScholarlyArticle",
"name": "G6PD and machine learning algorithms as prognostic and diagnostic indicators of liver hepatocellular carcinoma.",
"datePublished": "2024-01-31",
"url": "https://questionsmedicales.fr/article/38297250",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-024-11887-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhancing autonomous vehicle hyperawareness in busy traffic environments: A machine learning approach.",
"datePublished": "2024-01-25",
"url": "https://questionsmedicales.fr/article/38277854",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aap.2024.107458"
}
},
{
"@type": "ScholarlyArticle",
"name": "Machine learning in the prediction of massive transfusion in trauma: a retrospective analysis as a proof-of-concept.",
"datePublished": "2024-01-24",
"url": "https://questionsmedicales.fr/article/38265444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00068-023-02423-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Retroviridae",
"item": "https://questionsmedicales.fr/mesh/D012190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Rétrovirus simiens",
"item": "https://questionsmedicales.fr/mesh/D015301"
},
{
"@type": "ListItem",
"position": 6,
"name": "Virus de l'immunodéficience simienne",
"item": "https://questionsmedicales.fr/mesh/D015302"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus de l'immunodéficience simienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus de l'immunodéficience simienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus de l'immunodéficience simienne",
"description": "Comment diagnostiquer une infection par le SIV ?\nQuels tests sont utilisés pour le SIV ?\nLe SIV peut-il être confondu avec le VIH ?\nQuels sont les signes cliniques du SIV ?\nLe SIV est-il transmissible à l'homme ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Machine+Learning&page=998#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus de l'immunodéficience simienne",
"description": "Quels sont les symptômes du SIV chez les singes ?\nLe SIV provoque-t-il des symptômes immédiats ?\nComment le SIV affecte-t-il le système immunitaire ?\nY a-t-il des symptômes spécifiques au SIV ?\nLe SIV peut-il être asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Machine+Learning&page=998#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus de l'immunodéficience simienne",
"description": "Comment prévenir l'infection par le SIV ?\nLe SIV peut-il être transmis par voie sexuelle ?\nY a-t-il des mesures de prévention pour les chercheurs ?\nLes tests réguliers sont-ils recommandés ?\nLes animaux de compagnie peuvent-ils transmettre le SIV ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Machine+Learning&page=998#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus de l'immunodéficience simienne",
"description": "Quel est le traitement du SIV chez les primates ?\nLes antirétroviraux sont-ils efficaces contre le SIV ?\nLe SIV nécessite-t-il une hospitalisation ?\nY a-t-il des vaccins contre le SIV ?\nComment gérer les infections opportunistes liées au SIV ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Machine+Learning&page=998#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus de l'immunodéficience simienne",
"description": "Quelles sont les complications du SIV ?\nLe SIV peut-il entraîner des cancers ?\nComment le SIV affecte-t-il la reproduction ?\nLe SIV peut-il causer des troubles neurologiques ?\nY a-t-il des effets à long terme du SIV ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Machine+Learning&page=998#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus de l'immunodéficience simienne",
"description": "Quels sont les facteurs de risque du SIV ?\nLes personnes vivant avec des animaux sauvages sont-elles à risque ?\nLes chercheurs en primatologie sont-ils exposés au SIV ?\nLe SIV est-il plus fréquent chez certains primates ?\nLes voyages dans des zones endommagées augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Machine+Learning&page=998#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le SIV ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sérologiques détectant des anticorps anti-SIV."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le SIV ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et PCR sont couramment utilisés pour détecter le SIV."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il être confondu avec le VIH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes et les tests peuvent être similaires, nécessitant des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques du SIV ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, perte de poids et infections opportunistes."
}
},
{
"@type": "Question",
"name": "Le SIV est-il transmissible à l'homme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIV peut être transmis à l'homme, provoquant des infections similaires au VIH."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du SIV chez les singes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée, perte de poids et immunodéficience progressive."
}
},
{
"@type": "Question",
"name": "Le SIV provoque-t-il des symptômes immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent prendre des années à se manifester après l'infection."
}
},
{
"@type": "Question",
"name": "Comment le SIV affecte-t-il le système immunitaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIV cible les lymphocytes T, entraînant une diminution de la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques au SIV ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes spécifiques incluent des infections récurrentes et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il être asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains animaux peuvent être porteurs du SIV sans montrer de symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le SIV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des primates infectés et pratiquer une bonne hygiène."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il être transmis par voie sexuelle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIV peut être transmis par contact sexuel avec des primates infectés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures de prévention pour les chercheurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est essentielle."
}
},
{
"@type": "Question",
"name": "Les tests réguliers sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers peuvent aider à détecter une infection précoce."
}
},
{
"@type": "Question",
"name": "Les animaux de compagnie peuvent-ils transmettre le SIV ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, le SIV ne se transmet pas des animaux de compagnie aux humains."
}
},
{
"@type": "Question",
"name": "Quel est le traitement du SIV chez les primates ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique, mais des soins de soutien sont recommandés."
}
},
{
"@type": "Question",
"name": "Les antirétroviraux sont-ils efficaces contre le SIV ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antirétroviraux peuvent aider à contrôler l'infection chez les primates."
}
},
{
"@type": "Question",
"name": "Le SIV nécessite-t-il une hospitalisation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais une surveillance médicale est recommandée pour les cas graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins contre le SIV ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre le SIV."
}
},
{
"@type": "Question",
"name": "Comment gérer les infections opportunistes liées au SIV ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement des infections opportunistes est essentiel pour améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du SIV ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections opportunistes et des troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il entraîner des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immunodéficience peut augmenter le risque de certains cancers chez les primates."
}
},
{
"@type": "Question",
"name": "Comment le SIV affecte-t-il la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIV peut entraîner des problèmes de fertilité et des complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il causer des troubles neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison de l'infection chronique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme du SIV ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme incluent une immunodéficience persistante et des maladies associées."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du SIV ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le contact avec des primates infectés et des pratiques sexuelles à risque."
}
},
{
"@type": "Question",
"name": "Les personnes vivant avec des animaux sauvages sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec des animaux sauvages peut augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les chercheurs en primatologie sont-ils exposés au SIV ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont à risque en raison de leur travail avec des primates potentiellement infectés."
}
},
{
"@type": "Question",
"name": "Le SIV est-il plus fréquent chez certains primates ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines espèces de singes sont plus susceptibles d'être infectées par le SIV."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones endommagées augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le SIV est présent peut augmenter le risque d'exposition."
}
}
]
}
]
}
This study used an unsupervised machine learning algorithm, sidClustering and random forests, to identify clusters of risk behaviors of Bacterial Vaginosis (BV), the most common cause of abnormal vagi...
We identified four clusters, and variables were ranked by importance in distinguishing clusters: Cluster 1: nulliparous women who engaged in IVPs to clean themselves and please sexual partners, and us...
Machine learning methods may be particularly useful in identifying specific clusters of high-risk behaviors, in developing interventions intended to reduce BV and IVP, and ultimately in reducing the r...
Changes in error processing are observable in a range of anxiety-related disorders. Numerous studies, however, have reported contradictory and nonreplicating findings, thus the exact mapping of brain ...
Liver Hepatocellular carcinoma (LIHC) exhibits a high incidence of liver cancer with escalating mortality rates over time. Despite this, the underlying pathogenic mechanism of LIHC remains poorly unde...
To address this gap, we conducted a comprehensive investigation into the role of G6PD in LIHC using a combination of bioinformatics analysis with database data and rigorous cell experiments. LIHC samp...
Our findings revealed significantly elevated G6PD expression levels in liver cancer tissues as compared to normal tissues. Meanwhile, Nomogram and Adaboost, Catboost, and Gbdt Regression analyses show...
The potential diagnostic utility of G6PD and Decision Tree C5.0 for LIHC opens up a novel avenue for early detection and improved treatment strategies for hepatocellular carcinoma....
As autonomous vehicles (AVs) advance from theory into practice, their safety and operational impacts are being more closely studied. This study aims to contribute to the ever-evolving algorithms used ...
Early administration and protocolization of massive hemorrhage protocols (MHP) has been associated with decreases in mortality, multiorgan system failure, and number of blood products used. Various pr...
Using the National Trauma Data Bank from 2013 to 2018, we included severely injured trauma patients and extracted clinical features available from the pre-hospital and emergency department. We subsequ...
A total of 326,758 patients met our inclusion with 18,871 (5.8%) requiring massive transfusion. Emergency department models demonstrated strong performance characteristics with mean areas under the re...
We demonstrate the use of machine learning in developing an accurate prediction model for massive transfusion in trauma patients using early clinical data. This research demonstrates the potential uti...
Esophageal cancer (EC) is a highly prevalent and progressive disease. Early prediction of EC risk in the population is crucial in preventing this disease and enhancing the overall health of individual...
The current retrospective study was performed from 2018 to 2022 in Sari City based on 3256 EC and non-EC cases. The six selected algorithms, including Random Forest (RF), eXtreme Gradient Boosting (XG...
Comparing the performance efficiency of algorithms revealed that the XG-Boost model gained the best predictability for EC risk with AU-ROC = 0.92 and AU-ROC-test = 0.889 for internal and validation st...
This study showed that the XG-Boost could provide insight into the early prediction of the EC risk for people and clinical providers to stratify the high-risk group of EC and achieve preventive measur...
Machine learning has been increasingly used to obtain individualized neuroimaging signatures for disease diagnosis, prognosis, and response to treatment in neuropsychiatric and neurodegenerative disor...
Soil loss is an environmental concern of global importance. Accurate simulation of soil loss in small watersheds is crucial for protecting the environment and implementing soil and water conservation ...
Postpancreatectomy hemorrhage (PPH) is a rare yet dreaded complication following pancreaticoduodenectomy (PD). This retrospective study aimed to explore a machine learning (ML) model for predicting PP...
A total of 284 patients who underwent open PD at our institute were included in the analysis. To address the issue of imbalanced data, the adaptive synthetic sampling (ADASYN) technique was employed. ...
PPH occurred in 11 patients (3.9%), with a median onset time of 22 days postoperatively. These minority cases were oversampled to 85 using ADASYN. The extra trees classifier demonstrated superior perf...
This study highlights the potential of the ML approach to predict PPH occurrence following PD. Vigilance and early interventions guided by such model predictions could positively impact outcomes for h...
No-show to medical appointments has significant adverse effects on healthcare systems and their clients. Using machine learning to predict no-shows allows managers to implement strategies such as over...
In this study, we proposed a detailed analytical framework for predicting no-shows while addressing imbalanced datasets. The framework includes a novel use of z-fold cross-validation performed twice d...
From the academic perspective, our study is the first to propose using SR and IHT to predict the no-show of patients. Our findings indicate that SR and IHT presented superior performances compared to ...
This is the first study to use SR and IHT methods to predict patient no-shows and the first to propose performing z-fold cross-validation twice. Our study highlights the importance of avoiding relying...
